Revving Up for Success: Propanc Biopharma Announces Reverse Stock Split!
Welcome to the Future of Cancer Treatment Propanc Biopharma Announces Reverse Stock Split MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that the Company’s board of directors (the “Board”) has approved a reverse stock…